Literature DB >> 25957974

Associations of peripartum markers of stress and inflammation with milk yield and reproductive performance in Holstein dairy cows.

Juliana M Huzzey1, Sabine Mann2, Daryl V Nydam2, Richard J Grant3, Thomas R Overton4.   

Abstract

The objective was to evaluate the association of peripartum concentrations of fecal cortisol metabolites (11,17-dioxoandrostane; 11,17-DOA), plasma cortisol and haptoglobin (Hp), as well as two markers of negative energy balance, non-esterified fatty acid (NEFA) and postpartum β-hydroxybutyrate (BHBA), with milk yield and reproductive performance. Blood and fecal samples were collected weekly from 412 Holstein dairy cows from wk -3 through wk +1 relative to calving. Pregnancies by 150 days in milk (DIM) and projected 305-d mature equivalent (305ME) milk yield based on the 3rd Dairy Herd Improvement (DHI) test day (mean±SD; 102±17 DIM) were measured. Multivariable linear regression models were used to describe the associations of metabolites with 305ME milk yield. Semiparametric proportional hazards models were used to describe associations of the same metabolites with risk of conception by 150 DIM. Negative associations with milk yield were found for prepartum Hp in wk -2, -1, and +1 relative to calving (estimate±SE: 490±251, 564±259, and 464±136kg lower yield for every increase in Hp concentration by 1g/L, respectively) as well as with NEFA concentration in wk -2 (estimate±SE: 1465±541kg lower milk yield for an increase in NEFA concentration by 1mEq/L). Postpartum associations of NEFA with milk yield depended on parity; NEFA was associated with an increase in milk yield in primiparous animals only (estimate±SE: 1548±510kg increase for an increase in NEFA concentration by 1mEq/L). An increase in plasma cortisol concentration by 1μg/dL in wk +1 relative to calving was associated with an increase in milk yield (estimate±SE: 580±176kg). Prepartum 11,17-DOA was associated in all three prepartum sampling weeks with a reduced hazard ratio (HR) of conception (HR [95% CI]: 0.81 [0.67-0.97], 0.85 [0.72-0.99], and 0.85 [0.75-0.97] for every increase in concentration by 1mg/g fecal dry matter (DM) in wk -3, -2, and -1 relative to calving, respectively). Increased cortisol concentrations in wk -3 and -1 relative to calving were associated with decreased hazard of conception in primiparous animals only (HR [95% CI]: 0.54 [0.32-0.92] and 0.59 [0.35-0.99], respectively. Increases in postpartum metabolites Hp and BHBA had a negative association with hazard of conception (HR [95% CI]: 0.81 [0.70-0.97], 0.74 [0.56-0.98], respectively). Biomarkers of inflammation and stress around calving may be useful to assess opportunities for improved milk yield and reproduction.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cortisol; Fecal cortisol metabolites; Haptoglobin; Transition cow

Mesh:

Substances:

Year:  2015        PMID: 25957974     DOI: 10.1016/j.prevetmed.2015.04.011

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  13 in total

Review 1.  Nutrigenomic Interventions to Address Metabolic Stress and Related Disorders in Transition Cows.

Authors:  Faiz-Ul Hassan; Asif Nadeem; Maryam Javed; Muhammad Saif-Ur-Rehman; Muhammad Aasif Shahzad; Jahanzaib Azhar; Borhan Shokrollahi
Journal:  Biomed Res Int       Date:  2022-06-11       Impact factor: 3.246

Review 2.  Metabolic Disorders in the Transition Period Indicate that the Dairy Cows' Ability to Adapt is Overstressed.

Authors:  Albert Sundrum
Journal:  Animals (Basel)       Date:  2015-10-09       Impact factor: 2.752

3.  Immunometabolic Status during the Peripartum Period Is Enhanced with Supplemental Zn, Mn, and Cu from Amino Acid Complexes and Co from Co Glucoheptonate.

Authors:  Fernanda Batistel; Johan S Osorio; Annarita Ferrari; Erminio Trevisi; Michael T Socha; Juan J Loor
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

Review 4.  Potential of acute phase proteins as predictor of postpartum uterine infections during transition period and its regulatory mechanism in dairy cattle.

Authors:  A Manimaran; A Kumaresan; S Jeyakumar; T K Mohanty; V Sejian; Narender Kumar; L Sreela; M Arul Prakash; P Mooventhan; A Anantharaj; D N Das
Journal:  Vet World       Date:  2016-01-29

Review 5.  Metabolic and immunological changes in transition dairy cows: A review.

Authors:  Pratik Ramesh Wankhade; A Manimaran; A Kumaresan; S Jeyakumar; K P Ramesha; V Sejian; D Rajendran; Minu Rachel Varghese
Journal:  Vet World       Date:  2017-11-24

6.  Postpartum meloxicam administration alters plasma haptoglobin, polyunsaturated fatty acid, and oxylipid concentrations in postpartum ewes.

Authors:  Katie E Olagaray; Barry J Bradford; Lorraine M Sordillo; Jeffery C Gandy; Laman K Mamedova; Turner H Swartz; Trey D Jackson; Emma K Persoon; Caitlin S Shugart; Curtis R Youngs
Journal:  J Anim Sci Biotechnol       Date:  2020-07-01

7.  Parity and season affect hematological, biochemical, and milk parameters during the early postpartum period in grazing dairy cows from high-tropics herds.

Authors:  Dario Vallejo-Timarán; John Montoya-Zuluaga; Viviana Castillo-Vanegas; Juan Maldonado-Estrada
Journal:  Heliyon       Date:  2020-05-26

8.  Dietary supplementation of Scutellaria baicalensis extract during early lactation decreases milk somatic cells and increases whole lactation milk yield in dairy cattle.

Authors:  K E Olagaray; M J Brouk; L K Mamedova; S E Sivinski; H Liu; F Robert; E Dupuis; M Zachut; B J Bradford
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

9.  The Autumn Low Milk Yield Syndrome in High Genetic Merit Dairy Cattle: The Possible Role of a Dysregulated Innate Immune Response.

Authors:  Massimo Amadori; Chiara Spelta
Journal:  Animals (Basel)       Date:  2021-02-03       Impact factor: 2.752

Review 10.  Mismatch of Glucose Allocation between Different Life Functions in the Transition Period of Dairy Cows.

Authors:  Jonas Habel; Albert Sundrum
Journal:  Animals (Basel)       Date:  2020-06-13       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.